Pfizer, AstraZeneca vaccines effective against severe COVID-19, UK variant
27 May 2021
byStephen Padilla
Getting vaccinated with one dose of either the BNT162b2 (Pfizer-BioNTech) or ChAdOx1-S (Oxford-AstraZeneca) results in a significant decrease in symptomatic COVID-19 in older adults and in further protection against severe disease, according to a recent study in England. In addition, the Pfizer-BioNTech vaccine has shown efficacy against the B.1.1.7 or the UK variant.
Pfizer, AstraZeneca vaccines effective against severe COVID-19, UK variant
27 May 2021